113 related articles for article (PubMed ID: 8388792)
21. In-vitro activity of WIN 57273 compared to the activity of other fluoroquinolones and two beta-lactam antibiotics.
Chin NX; Neu HC
J Antimicrob Chemother; 1991 Jun; 27(6):781-91. PubMed ID: 1657856
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.
Sato K; Hoshino K; Tanaka M; Hayakawa I; Osada Y
Antimicrob Agents Chemother; 1992 Jul; 36(7):1491-8. PubMed ID: 1324647
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
Mirelis B; Navarro F; Miró E; Coll R; Xicota MA; Prats G
Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
[TBL] [Abstract][Full Text] [Related]
24. The in-vitro activity of Bay y 3118, a new chlorofluoroquinolone.
Wise R; Andrews JM; Brenwald N
J Antimicrob Chemother; 1993 Jan; 31(1):73-80. PubMed ID: 8383104
[TBL] [Abstract][Full Text] [Related]
25. In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone.
Gooding BB; Jones RN
Antimicrob Agents Chemother; 1993 Feb; 37(2):349-53. PubMed ID: 8043036
[TBL] [Abstract][Full Text] [Related]
26. Lomefloxacin: microbiologic assessment and unique properties.
Mayer KH; Ellal JA
Am J Med; 1992 Apr; 92(4A):58S-62S. PubMed ID: 1316073
[TBL] [Abstract][Full Text] [Related]
27. Comparative in vitro activity of a new quinolone, AM-1091.
Neu HC; Novelli A; Chin NX
Antimicrob Agents Chemother; 1989 Jul; 33(7):1036-41. PubMed ID: 2675753
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3-methyl-azetidinyl tricyclic fluoroquinolone.
Gargallo-Viola D; Esteve M; Llovera S; Roca X; Guinea J
Antimicrob Agents Chemother; 1991 Mar; 35(3):442-7. PubMed ID: 2039195
[TBL] [Abstract][Full Text] [Related]
29. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
Barry AL; Fuchs PC
J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of PD 117596-2, a broad-spectrum difluoroquinolone.
Neu HC; Chin NX
Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):644-50. PubMed ID: 2506029
[TBL] [Abstract][Full Text] [Related]
31. In-vitro activity of PD 131628, a new quinolone antimicrobial agent.
Cooper MA; Andrews JM; Wise R
J Antimicrob Chemother; 1992 May; 29(5):519-27. PubMed ID: 1320603
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of temafloxacin against gram-negative bacteria: an overview.
Hardy DJ
Am J Med; 1991 Dec; 91(6A):19S-23S. PubMed ID: 1662890
[TBL] [Abstract][Full Text] [Related]
33. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of CP-74667 compared with four other fluoroquinolones.
Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1992 Aug; 15(6):531-6. PubMed ID: 1330419
[TBL] [Abstract][Full Text] [Related]
35. Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent.
Gargallo-Viola D; Ferrer S; Tudela E; Robert M; Coll R; Roser R; Guinea J
Antimicrob Agents Chemother; 2001 Nov; 45(11):3113-21. PubMed ID: 11600365
[TBL] [Abstract][Full Text] [Related]
36. In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centers.
Sader HS; Jones RN; Allen SD; Gerlach EH; Murray PR; Washington JA
J Chemother; 1993 Oct; 5(5):283-8. PubMed ID: 8106899
[TBL] [Abstract][Full Text] [Related]
37. Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
Bauernfeind A
J Antimicrob Chemother; 1993 Apr; 31(4):505-22. PubMed ID: 7605398
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of AT-4140 against clinical bacterial isolates.
Kojima T; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1989 Nov; 33(11):1980-8. PubMed ID: 2558617
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone.
Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
Chemotherapy; 1992; 38(2):99-106. PubMed ID: 1317282
[TBL] [Abstract][Full Text] [Related]
40. [In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Matsuzaki K; Koyama H; Chiba A; Omika K; Harada S; Sato Y; Hasegawa M; Kobayashi I; Kaneko A; Sasaki J
Jpn J Antibiot; 1999 Sep; 52(9):571-84. PubMed ID: 10746192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
